Vertex Pharmaceuticals, Inc. (VRTX)
547.74
-0.31
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
548.20
+0.46
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.310 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.310 |
| March 31, 2026 | 4.024 |
| December 31, 2025 | 4.651 |
| September 30, 2025 | 4.204 |
| June 30, 2025 | 3.990 |
| March 31, 2025 | 2.491 |
| December 31, 2024 | 3.505 |
| September 30, 2024 | 4.005 |
| June 30, 2024 | -13.92 |
| March 31, 2024 | 4.211 |
| December 31, 2023 | 3.713 |
| September 30, 2023 | 3.973 |
| June 30, 2023 | 3.516 |
| March 31, 2023 | 2.688 |
| December 31, 2022 | 3.146 |
| September 30, 2022 | 3.586 |
| June 30, 2022 | 3.133 |
| March 31, 2022 | 2.955 |
| December 31, 2021 | 2.996 |
| September 30, 2021 | 3.280 |
| June 30, 2021 | 0.2564 |
| March 31, 2021 | 2.494 |
| December 31, 2020 | 2.296 |
| September 30, 2020 | 2.527 |
| June 30, 2020 | 3.179 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.287 |
| December 31, 2019 | 2.225 |
| September 30, 2019 | 0.2208 |
| June 30, 2019 | 1.029 |
| March 31, 2019 | 1.03 |
| December 31, 2018 | 5.97 |
| September 30, 2018 | 0.50 |
| June 30, 2018 | 0.80 |
| March 31, 2018 | 0.81 |
| December 31, 2017 | 0.39 |
| September 30, 2017 | -0.41 |
| June 30, 2017 | 0.07 |
| March 31, 2017 | 0.99 |
| December 31, 2016 | 0.13 |
| September 30, 2016 | -0.16 |
| June 30, 2016 | -0.26 |
| March 31, 2016 | -0.17 |
| December 31, 2015 | -0.31 |
| September 30, 2015 | -0.39 |
| June 30, 2015 | -0.78 |
| March 31, 2015 | -0.83 |
| December 31, 2014 | -0.74 |
| September 30, 2014 | -0.72 |
| June 30, 2014 | -0.68 |
| March 31, 2014 | -1.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -8.444 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Regeneron Pharmaceuticals, Inc. | 12.23 |
| Sionna Therapeutics, Inc. | -0.6619 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.100B |
| Revenue (Quarterly) | 3.344B |
| Total Expenses (Quarterly) | 2.244B |
| Enterprise Value | 132.96B |
| Gross Profit Margin (Quarterly) | 85.37% |
| Profit Margin (Quarterly) | 32.89% |
| Earnings Yield | 3.14% |
| Operating Earnings Yield | 3.58% |
| Normalized Earnings Yield | 3.224 |